Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...

Researchers have developed an advanced model that facilitates the study of drug metabolism during pregnancy by ...

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver condition that ...

"It is a long way from insights in mouse experiments to bringing a drug to the market – but this is obviously the potential ...

Metabolic Associated Fatty Liver Disease (MAFLD) has emerged as a global public health concern due to its increasing ...

Maintaining optimal digestive health is crucial for overall well-being in today's fast-paced world. Many individuals struggle ...

The company plans to resume its CATT1 Phase 3 trial for type 1 diabetes after submitting a protocol amendment.

liver failure or cancer. Currently, there is no approved drug that can stop the disease from getting worse, making it a major health concern. A recent study published on January 31, 2024 ...

More than 100 million Americans struggle with obesity and related metabolic disorders, a staggering number with widespread consequences. "We were really excited about this work," says S. Thai ...

A Potential Breakthrough in Liver Disease Treatment Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This gene plays an ...

Ready to save your liver? Transcription factors are paving the way for metabolic dysfunction-associated fatty liver disease ...

Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...